Showing results (251-260 of 275) with videos related to
Sort By:
Pageof 28
AIMS Public Health|December 23, 2015
Prescription Drug Diversion: Predictors of Illicit Acquisition and Redistribution in Three U.S. Metropolitan AreasShana Harris, Valentina Nikulina, Camila Gelpí-Acosta, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 19, 2021
Enhancing validity, reliability and participation in self-reported health outcome measurement for children and young people: a systematic review of recall period, response scale format, and administration modalityL Coombes, K Bristowe, C Ellis-Smith, et al.AIDS Care|February 3, 2011
Access to HIV community services by vulnerable populations: evidence from an enhanced HIV/AIDS surveillance systemH C E Madden, P A Phillips-Howard, S C Hargreaves, et al.Ultrasound in Medicine & Biology|December 2, 1998
Ultrasound echogenicity in experimental venous thrombosisJ B Fowlkes, R M Strieter, L J Downing, et al.Molecular Microbiology|January 12, 2008
The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitroBavesh D Kana, Bhavna G Gordhan, Katrina J Downing, et al.British Journal of Pharmacology|August 1, 1993
Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in bovine trachealis muscle: studies of mechanical activity and ion fluxesP Chiu, S J Cook, R C Small, et al.Human Reproduction (Oxford, England)|July 13, 2025
Bacterial vaginosis toxins impair sperm capacitation and fertilizationShweta Bhagwat, Leila Asadi, Ronald McCarthy, et al.Biorxiv : the Preprint Server for Biology|March 17, 2025
Bacterial Vaginosis Toxins Impair Sperm Capacitation and FertilizationShweta Bhagwat, Leila Asadi, Ronald McCarthy, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
IL-10 regulates thrombus-induced vein wall inflammation and thrombosisL J Downing, R M Strieter, A M Kadell, et al.Controlled Clinical Trials|October 2, 2001
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshopV G De Gruttola, P Clax, D L DeMets, et al.Pageof 28